Overview
Fulvio Riondato practices in Grugliasco, Italy. Mr. Riondato is rated as an Experienced expert by MediFind in the treatment of Acute Myelomonocytic Leukemia. His top areas of expertise are B-Cell Lymphoma, Non-Hodgkin Lymphoma, Diffuse Large B-Cell Lymphoma (DLBCL), and Acute Myelomonocytic Leukemia.
His clinical research consists of co-authoring 61 peer reviewed articles. MediFind looks at clinical research from the past 15 years. In particular, he has co-authored 1 article in the study of Acute Myelomonocytic Leukemia.
Locations
Clinical Research
Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.
Areas of Expertise
MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.
Learn more about MediFind’s expert tiers
- Advanced
- B-Cell LymphomaMr. Riondato isAdvanced. Learn about B-Cell Lymphoma.
- Diffuse Large B-Cell Lymphoma (DLBCL)Mr. Riondato isAdvanced. Learn about Diffuse Large B-Cell Lymphoma (DLBCL).
- Non-Hodgkin LymphomaMr. Riondato isAdvanced. Learn about Non-Hodgkin Lymphoma.
- Experienced
- Acute Myelomonocytic LeukemiaMr. Riondato isExperienced. Learn about Acute Myelomonocytic Leukemia.
- Follicular LymphomaMr. Riondato isExperienced. Learn about Follicular Lymphoma.
- HemochromatosisMr. Riondato isExperienced. Learn about Hemochromatosis.
- LeukemiaMr. Riondato isExperienced. Learn about Leukemia.
- Mantle Cell Lymphoma (MCL)Mr. Riondato isExperienced. Learn about Mantle Cell Lymphoma (MCL).
- Marginal Zone Lymphoma (MZL)Mr. Riondato isExperienced. Learn about Marginal Zone Lymphoma (MZL).